Journal Watch
Mortality patterns in PD & home HD differ from standard in-center HD
In the Australian dialysis database (ANZDATA), 4,298 deaths on PD and 10,338 on HD were analyzed for patterns. Patients who did PD, home HD, or in-center HD more than 3 days per week were equally likely to die on any day of the week. Not so for standard in-center HD patients: they were significantly more likely to die from heart-related reasons on Monday, after the 2-day no-treatment weekend.
Read the abstract » | (added 2013-02-27)
Tags:
Community house home hemodialysis in Australia and New Zealand
Not everyone who wants to dialyze at home is able to. In Australia and New Zealand unstaffed, non-medical community homes fill a gap to make "home" treatments possible. This observational study compared mortality among 113 community home dialyzers to 5,591 people on PD, 1,532 on home HD, and 5,647 on in-center HD. Community house HD was safe and effective.
Read the abstract » | (added 2012-12-19)
Tags:
Longer or more-frequent HD normalizes mortality patterns
It has long been known that those on PD have an equal chance of dying on any day of the week—while standard in-center HD are much more likely to die on a Monday (or Tuesday with Tue-Thu-Sat treatments). A new study looking at 14,636 Australian registry deaths found that those who got more than 3 standard in-center treatments per week or did home HD were no more likely to die on a Monday (or Tuesday) than any other day.
Read the abstract » | (added 2012-09-25)
Tags:
Metaanalysis: Later dialysis start is better for HD
Starting dialysis at a lower GFR allows more time for access placement and options education. But the U.S. trend has been to start earlier. A new metaanalysis of 17 studies found that starting dialysis at a higher GFR was linked with a significantly higher risk of all-cause mortality—in HD, but not PD. The mortality risk was lower when GFR was calculated than when it was estimated.
Read the abstract » | (added 2012-08-16)
Tags: Chronic kidney disease
Home HD and mortality risk in Australia and New Zealand
Researchers analyzed data from 26,016 patients in the ANZDATA registry (856,007 patient-months) to see if home HD helped people live longer. Compared to standard in-center HD, those on standard (3x/week), more-frequent, or nocturnal home HD were about twice as likely to survive.
Read the abstract » | (added 2011-08-25)
Tags:
87 people on nocturnal home HD for 12 years had just 30% the mortality of standard HD
How does survival of people on nightly home HD compare to those in the USRDS? A single-center study of 87 people who got 40±6 hours a week of HD found that 79% lived 5 years, and 64% lived for 10 years—a mortality rate just 30% of the USRDS average. Higher levels of education and more hours of dialysis were the only factors independently linked with survival.
Read the abstract » | (added 2011-04-25)
Tags:
Travel time to HD predicts HRQOL, adherence, & death
A new paper from the Dialysis Outcomes and Practice Patterns (DOPPS) study of 20,994 patients reports that patents whose one-way travel to HD was longer than 60 minutes had significantly higher mortality and lower quality of life. Patients noted, "I feel as if it rules all my time." The authors suggest home dialysis as an option for those who live far from the nearest center.
Read the abstract » | (added 2011-02-24)
Tags:
New study finds better survival with short daily home hemo
Compared to USRDS survival figures for conventional (3 times a week) in-center hemo, 117 people using short daily home hemo had a significantly lower standardized mortality rate, found a study by Drs. Blagg, Kjellstrand, Ting, and Young.
Read the abstract » | (added 2011-02-24)
Tags:
November 2006 Kidney International supplement focuses on PD
Is survival better on PD or HD? What factors predict PD success? What are best practices in PD catheter placement? Does use of biocompatible PD solution reduce peritonitis? Learn the answers to these and many other key PD questions in the November 2006 supplement of KI. (For kidney professionals who don't subscribe to Kidney International, we've compiled the links to all of the abstracts from the special supplement on PD (November 2006). You can find them below.
- Mortality studies comparing PD and HD: What do they tell us?
- French PD registry (RDPLF): Outline and main results
- PD in the US: Evaluation of outcomes in contemporary cohorts
- Selected best demonstrated practices in PD access
- Use of the embedded PD catheter: Experience and results from a North American Center
- Prevention of infectious complications in PD: Best demonstrated practices
- Microbiology and outcomes of peritonitis in North America
- Impact of new dialysis solutions on peritonitis rates
- Place of PD in the management of treatment-resistant congestive heart failure
- The role of PD in the management of treatment-resistant congestive heart failure: A European perspective
- Mitigating peritoneal membrane characteristics in modern PD therapy
- Profiles of automated PD prescriptions in the US 1997-2003
- Tidal PD: Its role in the current practice of PD
- The role of tidal PD in modern practice: A European perspective
- Glucose sparing in PD: Implications and metrics
- New insight of amino-acid based dialysis solutions
- Management of hyperlipidemia in patients on PD: Current approaches
- Structural requirements for a successful PD program
- Nosogogy: When the learner is a patient with chronic renal failure
- Patient retraining in PD: Why and when it is needed
- Patient and technique survival on peritoneal dialysis in patients with failed renal allograft: A case-control study
- Place of genotyping and phenotyping in understanding and potentially modifying outcomes in PD patients
Read the abstract » | (added 2011-02-24)
Tags: